DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 06 · Volume 34 · November 2001 DOI: 10.1055/s-002-1233

Mitteilungen

1
Modell, S.; Holsboer, F.: Mitteilungen der Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)

Original Paper

217
Vormfelde, S. V.; Poser, W.: Death Attributed to Methadone
223
Baptista, T.; Lacruz, A.; Angeles, F.; Silvera, R.; de Mendoza, S.; Mendoza, M. T.; Hernández, L.: Endocrine and Metabolic Abnormalities Involved in Obesity Associated with Typical Antipsychotic Drug Administration
232
Tsutsumi, T.; Akiyoshi, J.; Hikichi, T.; Kiyota, A.; Kohno, Y.; Katsuragi, S.; Yamamoto, Y.; Isogawa, K.; Nagayama, H.: Suppression of Conditioned Fear by Administration of CCKB Receptor Antisense Oligodeoxynucleotide into the Lateral Ventricle
238
Lam, L. C. W.; Garcia-Barcelo, M. M.; Ungvari, G. S.; Tang, W. K.; Lam, V. K. L.; Kwong, S. L.; Lau, B. S. T.; Kwong, P. P. K.; Waye, M. M. Y.; Chiu, H. F. K.: Cytochrome P450 2D6 Genotyping and Association with Tardive Dyskinesia in Chinese Schizophrenic Patients

Review

242
Dietrich, D. E.; Kropp, S.; Emrich, H. M.: Oxcarbazepine in Affective and Schizoaffective Disorders

Short Communication

251
Braus, D. F.; Ende, G.; Weber-Fahr, W.; Demirakca, T.; Henn, F. A.: Favorable Effect on Neuronal Viability in the Anterior Cingulate Gyrus due to Long-Term Treatment with Atypical Antipsychotics: An MRSI Study

Case Report

254
Kaschka, W. P.; Meyer, A.; Schier, K. R.; Fröscher, W.: Treatment of Pathological Crying with Citalopram
259
Pedrosa Gil, F.; Grohmann, R.; Rüther, E.: Asymptomatic Bradycardia Associated with Amisulpride

Letter to the Editor

262
Dose, M.: Neuroleptic-Induced Pseudo-Catatonia

Letter to the editor

263
Deuschle, M.: Reply by the authors
264
Hesslinger, B.; Walden, J.; Normann, C.: Reply from the authors